Price
$9.75
Increased by +1.67%
Dollar Volume
6.76 M
ADR%
5.64
Earnings Report Date (estimate)
Nov 3, 22 (N/A)
Market Cap.
1.02 B
Shares Float
68.07 M
Shares Outstanding
104.66 M
Beta
1.41
Price / Earnings
-5.90
BPR
199.08
20D Range
8.83 10.65
50D Range
7.68 10.90
200D Range
5.73 13.65
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 3, 22 -0.35
Increased by +18.60%
-0.30
Decreased by -16.67%
Aug 4, 22 -0.36
Increased by +7.69%
-0.29
Decreased by -24.14%
May 5, 22 -0.43
Decreased by -65.38%
-0.30
Decreased by -43.33%
Mar 1, 22 -0.40
Decreased by -14.29%
-0.31
Decreased by -29.03%
Nov 4, 21 -0.43
Decreased by -79.17%
-0.25
Decreased by -72.00%
Aug 3, 21 -0.39
Decreased by -56.00%
-0.19
Decreased by -105.26%
May 6, 21 -0.26
Increased by +21.21%
-0.20
Decreased by -30.00%
Mar 4, 21 -0.35
Decreased by -25.00%
-0.21
Decreased by -66.67%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 89.84 M
Increased by +42.87%
-37.00 M
Increased by +14.02%
Decreased by -41.18%
Increased by +39.82%
Jun 30, 22 84.15 M
Increased by +35.18%
-37.32 M
Increased by +2.32%
Decreased by -44.35%
Increased by +27.74%
Mar 31, 22 70.93 M
Increased by +60.77%
-42.84 M
Decreased by -87.07%
Decreased by -60.40%
Decreased by -16.36%
Dec 31, 21 73.96 M
Increased by +68.27%
-40.19 M
Decreased by -49.96%
Decreased by -54.33%
Increased by +10.88%
Sep 30, 21 62.88 M
Increased by +52.76%
-43.03 M
Decreased by -174.63%
Decreased by -68.43%
Decreased by -79.78%
Jun 30, 21 62.25 M
Increased by +110.09%
-38.20 M
Decreased by -141.73%
Decreased by -61.37%
Decreased by -15.06%
Mar 31, 21 44.12 M
Increased by +46.51%
-22.90 M
Decreased by -10.53%
Decreased by -51.91%
Increased by +24.56%
Dec 31, 20 43.95 M
Increased by +35.86%
-26.80 M
Decreased by -57.35%
Decreased by -60.97%
Decreased by -15.82%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.